Search
Penumbra Inc
PENAdd to Watchlist
316.310USD
-0.890-0.28%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
12.41BMarket Cap
72.25P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Penumbra Inc is 6.59, ranking 161 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 320.00, with a high of 355.00 and a low of 266.00.
Analyst Rating
Based on
17
analysts
Hold
Current Rating
368.875
Target Price
+16.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Penumbra Inc
PEN
17
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Penumbra Inc's expected revenue for the next quarter?
Penumbra Inc's expected revenue is 389.01M.
What is Penumbra Inc's price target?
Analysts forecast that Penumbra Inc's price target is USD 320.00, with the highest forecast at USD 355.00 and the lowest forecast at USD 266.00.
How have Penumbra IncPEN's recent earnings per share performed?
The market expectation was USD 0.83, while Penumbra IncPEN's earnings per share (EPS) for the previous quarter was USD 1.21. EPS for the next quarter is expected at USD 1.19.
What is the analyst rating for Penumbra Inc?
Based on the ratings of Penumbra Inc's stock from 17 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
